Home › Head and Neck Squamous Cell Carcinoma › New York › Syracuse
Head and Neck Squamous Cell Carcinoma clinical trials in Syracuse, NY
3 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #76, Syracuse
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- State University of New York Upstate Medical University, Syracuse
- SUNY Upstate Medical Center-Community Campus, Syracuse
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Hematology-Oncology Associates of Central New York, Syracuse
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Non-Muscle Invasive Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Endometrial Cancer7 studies
- Obesity6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Macular Degeneration5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.